MAKO Surgical Corp. 4
4 · MAKO Surgical Corp. · Filed Dec 17, 2013
Insider Transaction Report
Form 4
MOLL FREDERIC H
Director
Transactions
- Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$22.90/sh−3,300$75,570→ 0 totalExercise: $7.10Exp: 2019-01-27→ Common Stock (3,300 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$17.13/sh−3,300$56,529→ 0 totalExercise: $12.87Exp: 2020-06-10→ Common Stock (3,300 underlying) - Disposition to Issuer
Common Stock
2013-12-17$30.00/sh−234,168$7,025,040→ 0 total - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$2.93/sh−3,300$9,669→ 0 totalExercise: $27.07Exp: 2021-06-16→ Common Stock (3,300 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$18.36/sh−17,317$317,940→ 0 totalExercise: $11.64Exp: 2023-06-04→ Common Stock (17,317 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$18.88/sh−9,900$186,911→ 0 totalExercise: $11.12Exp: 2017-08-24→ Common Stock (9,900 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$22.34/sh−2,475$55,292→ 0 totalExercise: $7.66Exp: 2019-08-24→ Common Stock (2,475 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2013-12-17$4.54/sh−3,338$15,155→ 0 totalExercise: $25.46Exp: 2022-06-11→ Common Stock (3,338 underlying) - Disposition to Issuer
Common Stock Warrant (right to buy)
2013-12-17$27.00/sh−11,279$304,533→ 0 totalExercise: $3.00Exp: 2014-12-17→ Common Stock (11,279 underlying) - Disposition to Issuer
Common Stock Warrant (right to buy)
2013-12-17$22.56/sh−8,065$181,946→ 0 totalExercise: $7.44Exp: 2015-11-02→ Common Stock (8,065 underlying)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger ("Merger Agreement"), dated September 25, 2013, by and among the issuer, Stryker Corporation, and Lauderdale Merger Corporation, each share of the issuer's common stock was exchanged for a cash payment of $30.00.
- [F2]Pursuant to the Merger Agreement, each outstanding stock option, whether vested or unvested, was canceled in exchange for a cash payment equal to the amount, if any, by which $30.00 exceeded the exercise price payable per share under each such stock option.
- [F3]Pursuant to the Merger Agreement, each outstanding warrant was canceled in exchange for a cash payment equal to the amount by which $30.00 exceeded the exercise price payable per share under each such warrant.